Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 47Polycystic Ovary Syndrome 6Infertility 2Hyperandrogenism 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunction, Physiological 1Prostatic Intraepithelial Neoplasia 1Prostate Adenocarcinoma 1Primary Dysautonomias 1Overweight 1Ovarian Neoplasms 1Oligomenorrhea 1Neoplasm Metastasis 1Metabolic Syndrome 1Kidney Diseases 1Insulin Resistance 1Hypertension 1Hirsutism 1Castration-resistant Prostate Cancer 1Carcinoma, Ovarian Epithelial 1Anovulation 1Amenorrhea 1Adenocarcinoma 1

Interventions

Musculoskeletal Manipulations 2drospirenone and ethinyl estradiol combination 1Tamoxifen 1Surveys and Questionnaires 1Radiotherapy 1Postoperative Period 1Metformin 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Inositol 1Flutamide 1Epirubicin 1Docetaxel 1Cyproterone acetate, ethinyl estradiol drug combination 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Amenorrhea × Flutamide × Clear all
NCT01889199 2025-01-10

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

University of California, Los Angeles

Phase 2 Completed
23 enrolled 12 charts

Amenorrhea, Anovulation, Hirsutism, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡